Sameness Index · 4 sites compared

Your page scores 64 out of 100 for sameness against the 3 competitors you named.

https://intelliguardhealth.com/

01

Your verdict

64
Sameness · vs 3 named
How is this calculated?

Your page is mostly the same.

Most of what your page says, BD Pyxis™ says too. You're less same than 92 of the 366 SaaS sites scored (SaaS avg 56).

No category benchmark matched this set.
Sameness Index on a 0 to 100 scale, from distinctive at 0 to interchangeable at 100. This page scores 64. Bluesight scores 61. Omnicell scores 48. BD Pyxis™ scores 39. The SaaS avg is 56.

Each named site is scored the same way, against the other 3 in this set, so its tick means the same as your marker. The dashed line is the frozen benchmark average.

  1. More same than average

    The average SaaS site scores 56; you scored 64.

    You are 8 points more same than the average SaaS site.

  2. Closest overlap: BD Pyxis™

    Of the 3 sites you named, BD Pyxis™ echoes the most of what your page says. Scored the same way against the rest of the set, BD Pyxis™ sits at 39.

    BD Pyxis™ is the competitor you sound most like.

  3. Room to own more

    25% of your claim space is ownable: unique, relevant, and hard to copy. 2 of those claims sit in body copy, where few readers reach them.

    25% is ownable, and 2 buried opportunities could help you stand out more.

Do this first

Three changes worth testing first.

Chosen by rule from the comparison with Bluesight, Omnicell and BD Pyxis™: the shared claim taking your most prominent space, then the claims only you make that sit too low on the page to be read. Each one links to its claim card.

  1. Know Exactly Where Every Critical, High-Value Medication is in Real Time

    Bluesight, Omnicell and BD Pyxis™ all say it too. Buyers may still need it, but shared ground cannot carry your hero — move it lower and give that space to something only you can say.

    Table stakes
    Most of the set says this too.
  2. Temperature excursion, expiry, and recall alerts pushed to you

    Nobody in the set says this. It sits in body copy, where few readers reach it — worth testing higher up the page; only buyers can tell you whether it lands.

    Surface
    Yours alone. Test it higher up.
  3. Every transaction tracked to the provider and patient

    A claim that is yours alone, filed in body copy. Try it where it will be read before the shared claims are, and let buyers tell you if it moves them.

    Surface
    Yours alone. Test it higher up.

Try these changes, then test them with real buyers.

This measures overlap. Whether buyers notice is a different question, and only they can answer it.

02

What you can own

Claims only you make, that buyers weigh, and that competitors can’t easily copy.

25% of your page’s claim space is yours to keep.

25%Yours to keep40%Unique but weak35%A competitor says it too
Why this is not 100 minus the Sameness Index

The index is a weighted composite across six categories, including page structure and visuals. This bar is measured on your claims alone, weighted by where each one sits on the page. Different denominators, so the two never add to 100 and are not meant to.

Already leading with · 5

  1. Real-time item-level visibility of every dose

    Know Exactly Where Every Critical, High-Value Medication is in Real Time

  2. Fast secure OR medication access without workflow disruption

    Mira Care Workstation offers fast, secure medication access in the OR without disrupting clinical workflows

  3. Large installed base of hospital customers

    600+ Hospitals Served

  4. Modular plug-and-play expansion across settings

    Plug-and-play expansion across central distribution, pharmacy, point of care, and enterprise intelligence

  5. Quantified medication identification/inventory accuracy rates

    99% medication identification accuracy

Buried in body copy · 2

  1. Transactions traced to provider and patient

    Every transaction tracked to the provider and patient

  2. Temperature, expiry and recall alerts pushed to users

    Temperature excursion, expiry, and recall alerts pushed to you

03

Where you blend in

Territory you spend prominent space on that the set also occupies. Not every line is one to delete — the question is whether it has earned the space, or whether something only you can say should be there instead.

  • Commodity · 100%Table stakesHero
    Real-time item-level inventory visibility and accuracy
    • Know Exactly Where Every Critical, High-Value Medication is in Real Time
    • Real-time accuracy

    You say this 2 different ways.

    Bluesight, Omnicell and BD Pyxis™ all cover this territory. Buyers may need to hear it, but in your hero it spends the first impression on shared ground. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

    They say
    • BluesightAutomated inventory tracking you can trust
    • OmnicellGain supply chain control
    • BD Pyxis™MedBank solutions focus on automating medication inventory management processes
  • Commodity · 67%KeepHero
    Single unified platform, one vendor
    • One Ecosystem. Total Control.

    Bluesight and BD Pyxis™ say what they are and who they are for, as every page in a category must. Keep it — it is orientation, not differentiation. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

    They say
    • Bluesightintegrating data from wholesalers, health records, dispensing cabinets, and HR systems
    • BD Pyxis™BD Pyxis™ Logistics has allowed us to close gaps. We took various streams of data and we put them into one system
  • Commodity · 100%Table stakesSection
    Improves compliance, audit readiness and lowers risk
    • Stronger compliance and audit readiness

    Common ground with Bluesight, Omnicell and BD Pyxis™. Say it if buyers need it — lower on the page, where it is not the thing they read first.

    They say
    • Bluesightstronger compliance
    • OmnicellSupport compliance
    • BD Pyxis™clear need for greater medication management consistency to reduce risk and enhance patient safety
  • Commodity · 100%Table stakesSection
    Reduces waste and lowers cost
    • Better financial control
    • Reduced waste and expiration loss

    You say this 2 different ways.

    Bluesight, Omnicell and BD Pyxis™ make the same claim. It cannot set you apart, so it should not carry the section.

    They say
    • Bluesightfinancial outcomes you can demonstrate to leadership
    • OmnicellReduce medication waste and realize cost savings
    • BD Pyxis™Intercept errors, reduce waste and optimize IV workflows
  • Commodity · 100%Table stakesSection
    Saves staff time through automation
    • Less manual work, more clinical focus

    A buyer comparing tabs sees this on Bluesight, Omnicell and BD Pyxis™. Yours earns nothing by repeating it up top; it can live lower down.

    They say
    • BluesightFrom procurement to compliance, we automate workflows to save time and boost efficiency
    • OmnicellAutomating manual tasks allows staff to focus on higher value activities
    • BD Pyxis™freeing your staff to work at the top of their licenses
  • Commodity · 67%Table stakesSection
    AI and analytics turn data into actionable decisions
    • Mira Intelligence+ is context-aware software that unifies medication data and delivers predictive insights

    Bluesight and Omnicell got here first as far as a buyer can tell. Keep the fact for readers who need it; move the position to a claim only your page can make.

    They say
    • BluesightPrism proactively monitors procurement, inventory, diversion, and privacy data, surfacing what needs attention before your team has to ask
    • OmnicellProviding visibility and insights to the pharmacy supply chain
  • Commodity · 67%Table stakesSection
    Quantified performance results as proof
    • 99% medication identification accuracy

    A buyer comparing tabs sees this on Bluesight and BD Pyxis™ too (67% of the set). Yours earns nothing by repeating it up top; it can live lower down. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

    They say
    • BluesightTeams using Prism Assistant have cut analysis and reporting time by up to 97%
    • BD Pyxis™You can cut refill time in half with BD Pyxis™ solutions
  • Contested · 33%KeepHero
    RFID-based medication tracking capability
    • Intelliguard is the only connected RFID ecosystem for medication inventory management
    • RFID Medication Inventory Management for Health Systems
    • RFID Patents

    You say this 3 different ways.

    BD Pyxis™ say what they are and who they are for, as every page in a category must. Keep it — it is orientation, not differentiation.

    They say
    • BD Pyxis™IntelliCab™ Will-Call System uses RFID technology to automatically track stored medications and provide near real time visibility
  • Contested · 33%SharpenSection
    Enterprise-wide control across facilities and scale
    • Plug-and-play expansion across central distribution, pharmacy, point of care, and enterprise intelligence
    • Enterprise-wide control

    You say this 2 different ways.

    BD Pyxis™ is on this territory too (33% of the set). It narrows the field without winning it — make it specific enough that it cannot be said of them.

    They say
    • BD Pyxis™comprehensive system of automated dispensing solutions and pharmacy technologies across your healthcare system
  • Contested · 33%SharpenSection
    Faster, undisrupted clinical workflow access
    • Mira Care Workstation offers fast, secure medication access in the OR without disrupting clinical workflows

    Shared with BD Pyxis™. Sharpen it to the thing only you do here, or it reads as a claim any of you could make. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

    They say
    • BD Pyxis™Enhance medication availability while increasing security and control of medications and supplies
  • Contested · 33%SharpenSection
    Legacy or generic tools fall short
    • Medication risk has shifted to high-value, high-risk therapies, but systems were built for volume, not item-level precision

    Bluesight is on this territory too (33% of the set). It narrows the field without winning it — make it specific enough that it cannot be said of them. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

    They say
    • BluesightPurpose-Built AI for Healthcare Teams
  • Contested · 33%SharpenSection
    Problem framing statistics about hospitals
    • A single hospital may manage 120,000 medications across pharmacies, ORs, infusion clinics, and procedural environments

    Contested ground: BD Pyxis™ claim it as well. The version that wins names a mechanism, a number or a scope that theirs cannot match. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

    They say
    • BD Pyxis™68% of medication errors occurring during administration
04

Claim-by-claim evidence

Every claim on your page (29)
What the columns mean
Claim
The grouped claim, then your exact line beneath it.
Type
What kind of claim it is: category, segment, outcome, capability, quality or proof.
Placement
Where it sits on your page: hero, section or body copy. Hero claims weigh most in the index.
Same claim
Share of the competitors making this exact claim. Drives ownership and ownable share.
Same territory
Share of the competitors with any claim in the same buyer-facing territory. This is what the index is scored on.
Sayability
Whether a competitor could truthfully make the same claim: anyone could, copyable with effort, or hard to copy.
Relevant
Whether buyers decide on this. A unique claim nobody buys on is not ownable.
Ownership
Commodity: 60% or more of the set says it. Contested: 20–59%. Unique: under 20%, owned when it is also hard to copy.

Tap a column to sort by it; tap again to reverse. Sorted by Same claim, highest first.

  • Better financial control and cost savings
    Better financial control
    outcomeSectionsame claim 67%same territory 100%Anyone could say it
    Commodity
    Also on Bluesight, Omnicell
  • Less manual work frees staff for clinical care
    Less manual work, more clinical focus
    outcomeSectionsame claim 67%same territory 100%Anyone could say it
    Commodity
    Also on Omnicell, BD Pyxis™
  • Reduce medication waste and expiration loss
    Reduced waste and expiration loss
    outcomeSectionsame claim 67%same territory 100%Anyone could say it
    Commodity
    Also on Omnicell, BD Pyxis™
  • Software unifies data and gives predictive insights
    Mira Intelligence+ is context-aware software that unifies medication data and delivers predictive insights
    capabilitySectionsame claim 67%same territory 67%Anyone could say it
    Commodity
    Also on Bluesight, Omnicell
  • Stronger compliance and audit readiness
    Stronger compliance and audit readiness
    outcomeSectionsame claim 67%same territory 100%Anyone could say it
    Commodity
    Also on Bluesight, Omnicell
  • Single view integrating RFID, EHR, cabinets, other systems
    One unified view across RFID, EHR, ADCs, and other systems
    capabilityBodysame claim 67%same territory 67%Copyable with effort
    Commodity
    Also on Bluesight, BD Pyxis™
  • RFID-based medication inventory tracking
    RFID Medication Inventory Management for Health Systems
    categoryHerosame claim 33%same territory 33%Copyable with effort
    Contested
    Also on BD Pyxis™
  • Enterprise-wide control across all facilities
    Enterprise-wide control
    capabilitySectionsame claim 33%same territory 33%Anyone could say it
    Contested
    Also on BD Pyxis™
  • Chain of custody helps prevent diversion
    A visible chain of custody to help prevent diversion
    capabilityBodysame claim 33%same territory 100%Copyable with effort
    Contested
    Also on Bluesight
  • Reduce on-hand inventory and surface savings
    Reduce on-hand inventory and surface immediate savings opportunities
    outcomeBodysame claim 33%same territory 100%Anyone could say it
    Contested
    Also on BD Pyxis™
  • Utilization data supports charge capture and 340B
    Precise utilization data for charge capture and 340B reconciliation
    outcomeBodysame claim 33%same territory 67%Copyable with effort
    Contested
    Also on Bluesight
  • A single unified platform, not point components
    One Ecosystem. Total Control.
    categoryHerosame claim 0%same territory 67%Anyone could say it
    Unique for now
  • Only/first connected RFID ecosystem in category
    Intelliguard is the only connected RFID ecosystem for medication inventory management
    categoryHerosame claim 0%same territory 33%Hard to copynot a buying criterion
    Unique and owned
  • Real-time item-level visibility of every dose
    Know Exactly Where Every Critical, High-Value Medication is in Real Time
    outcomeHerosame claim 0%same territory 100%Copyable with effort
    Unique and owned
  • Fast secure OR medication access without workflow disruption
    Mira Care Workstation offers fast, secure medication access in the OR without disrupting clinical workflows
    outcomeSectionsame claim 0%same territory 33%Copyable with effort
    Unique and owned
  • Holds RFID patents
    RFID Patents
    proofSectionsame claim 0%same territory 33%Hard to copynot a buying criterion
    Unique and owned
  • Hospitals manage enormous medication counts across sites
    A single hospital may manage 120,000 medications across pharmacies, ORs, infusion clinics, and procedural environments
    proofSectionsame claim 0%same territory 33%Anyone could say itnot a buying criterion
    Unique for now
  • Instant self-serve savings estimate in 60 seconds
    See your facility's Mira savings in 60 seconds
    outcomeSectionsame claim 0%same territory 0%Anyone could say itnot a buying criterion
    Unique for now
  • Large installed base of hospital customers
    600+ Hospitals Served
    proofSectionsame claim 0%same territory 0%Copyable with effort
    Unique and owned
  • Legacy systems built for volume, not precision
    Medication risk has shifted to high-value, high-risk therapies, but systems were built for volume, not item-level precision
    capabilitySectionsame claim 0%same territory 33%Anyone could say itnot a buying criterion
    Unique for now
  • Modular plug-and-play expansion across settings
    Plug-and-play expansion across central distribution, pharmacy, point of care, and enterprise intelligence
    capabilitySectionsame claim 0%same territory 33%Copyable with effort
    Unique and owned
  • Quantified medication identification/inventory accuracy rates
    99% medication identification accuracy
    proofSectionsame claim 0%same territory 67%Copyable with effort
    Unique and owned
  • Real-time data accuracy
    Real-time accuracy
    qualitySectionsame claim 0%same territory 100%Anyone could say it
    Unique for now
  • Volume of medications tracked to date
    50M+ Medications Tracked
    proofSectionsame claim 0%same territory 0%Copyable with effortnot a buying criterion
    Unique and owned
  • Case-level accountability across clinical roles
    Case-level accountability across anesthesiology, surgery, and nursing
    capabilityBodysame claim 0%same territory 33%Copyable with effortnot a buying criterion
    Unique and owned
  • Models multi-year savings across waste, charge capture, 340B
    Model annual and 5-year savings across drug waste, charge capture, and 340B revenue
    capabilityBodysame claim 0%same territory 0%Copyable with effortnot a buying criterion
    Unique and owned
  • Role-based prioritized actions rather than dashboards
    Prioritized, role-based actions, not just dashboards
    capabilityBodysame claim 0%same territory 67%Anyone could say itnot a buying criterion
    Unique for now
  • Temperature, expiry and recall alerts pushed to users
    Temperature excursion, expiry, and recall alerts pushed to you
    capabilityBodysame claim 0%same territory 0%Copyable with effort
    Unique and owned
  • Transactions traced to provider and patient
    Every transaction tracked to the provider and patient
    capabilityBodysame claim 0%same territory 100%Copyable with effort
    Unique and owned
05

How this was calculated

Sameness measures how much your claims overlap with the sites compared. It does not measure message quality or whether buyers prefer you.

AI-analyzed: an AI read each page on its own and grouped the claims that say the same thing. No score here was written by a model — every number is computed from those groupings in our own code, with the weights below.

How the score is built
The six category scores, their weights, and what a high score in each one means
CategoryWeightYoursWhat a high score means
Messaging
Category framing, who it is for, and the outcome promised
30%66The most expensive kind of sameness. A buyer cannot tell what job you do that the others do not.
Claims
Attribute and benefit claims — speed, ease, quality, ROI
30%100Every shared claim is a line already read on another tab. Cut the ones nobody owns and spend the space on something they cannot.
Features
Capabilities and functions the page lists
15%46Expected in a mature category, and the least alarming of the six. Feature parity is normal; leading with it is the mistake.
Proof
The kinds of evidence offered: customer logos, numbers, testimonials, case studies, badges
10%16Same kinds of proof as everyone means the proof stops working as proof. It is scored on the kind of evidence, not on which customers are named.
Structure
Section order, navigation, CTA language and placement
10%39The generic SaaS template — hero, logos, three-feature grid, testimonial, CTA. Familiar is not the same as memorable.
Visual
Palette family, imagery style, layout patterns
5%48Weighted lowest on purpose: buyers rarely decide on this. Worth knowing, rarely worth fixing first.

Each site was read on its own first, with no knowledge of the others, so your page gets no benefit of the doubt a competitor’s does not. A category nothing could be measured for drops out and the rest are re-weighted, rather than counted as zero.

What we compared (4 pages read)
Your page
Intelliguard
intelliguardhealth.com
Competitor
Bluesight
bluesight.com
Competitor
Omnicell
omnicell.com
Competitor
BD Pyxis™
bd.com
What it cannot tell you

The index can find where two pages converge. It cannot say whether a buyer would notice, or which of your reasons to buy actually land. A single check also moves several points between runs, so read the band and the ranking, not the last digit.

Your highest-impact changes

  1. 1
    Table stakesYour hero copy says “Know Exactly Where Every Critical, High-Value Medication is in Real Time”.

    Bluesight, Omnicell and BD Pyxis™ all say it too. Buyers may still need it, but shared ground cannot carry your hero — move it lower and give that space to something only you can say.

  2. 2
    Table stakesYour section copy says “Better financial control”.

    Keep the fact, lose the position: bluesight, Omnicell and BD Pyxis™ all say it too, and your section is spending its first impression on the same territory as theirs.

  3. 3
    Table stakesYour section copy says “Less manual work, more clinical focus”.

    This is the set's common ground — Bluesight, Omnicell and BD Pyxis™ all say it too. It will not set you apart wherever it sits, and in the section it costs you the one place a distinctive claim would be read.

  4. 4
    Table stakesYour section copy says “Real-time accuracy”.

    A buyer with three tabs open reads a version of this on every one of them. Say it further down for the readers who need it; the section should carry a claim they will only find here.

  5. 5
    Table stakesYour section copy says “Reduced waste and expiration loss”.

    True of you and true of them: Bluesight, Omnicell and BD Pyxis™ all say it too. That is why it decides nothing, and why the section is the wrong place to spend it.

  6. 6
    Table stakesYour section copy says “Stronger compliance and audit readiness”.

    In the section: Bluesight, Omnicell and BD Pyxis™ all say it too. Buyers may still need it, but shared ground cannot carry your section — move it lower and give that space to something only you can say.

  7. 7
    Table stakesYour section copy says “99% medication identification accuracy”.

    In the section: True of you and true of them: Bluesight and BD Pyxis™ say it too (67% of the set). That is why it decides nothing, and why the section is the wrong place to spend it.

  8. 8
    Table stakesYour section copy says “Mira Intelligence+ is context-aware software that unifies medication data and delivers predictive insights”.

    In the section: Keep the fact, lose the position: bluesight and Omnicell say it too (67% of the set), and your section is spending its first impression on the same territory as theirs.

  9. 9
    Surface“Temperature excursion, expiry, and recall alerts pushed to you” is yours alone, and buyers weigh it.

    Nobody in the set says this. It sits in body copy, where few readers reach it — worth testing higher up the page; only buyers can tell you whether it lands.

  10. 10
    Surface“Every transaction tracked to the provider and patient” is yours alone, and buyers weigh it.

    A claim that is yours alone, filed in body copy. Try it where it will be read before the shared claims are, and let buyers tell you if it moves them.

The only way to know if it matters.

This report can tell you where your messaging overlaps. It cannot tell you whether a buyer would care, or which of your reasons to buy actually land. Put the page in front of real B2B buyers in your target market and ask them.

Test it with real buyers
Trusted by
HubSpotRingCentralShopifyCognismPaddleVeeamRipplingMiro